Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Stebbing

Showing results (381-390 of 504) with videos related to

Pageof 51
Sort By:
Heliyon|November 3, 2023
A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing dataZhonghai Du, Tongtong Zhang, Yanke Lin, et al.
Journal of Clinical Pathology|May 19, 2011
Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talkJustin Stebbing, Arun Thiyagarajan, Veena Surendrakumar, et al.
Lancet (London, England)|August 28, 2015
The role of TP53 in miRNA loading onto AGO2 and in remodelling the miRNA-mRNA interaction networkJonathan Krell, Justin Stebbing, Adam Enver Frampton, et al.
Oncogene|April 8, 2022
PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38<sup>MAPK</sup> signallingRosemary Lane, Chiara Cilibrasi, Jianing Chen, et al.
European Journal of Haematology|September 10, 2009
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaEleftheria Hatzimichael, Aggeliki Dasoula, Reshma Shah, et al.
Plos One|May 14, 2013
The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept studyJustin Stebbing, Rachel Payne, Justine Reise, et al.
Oncoimmunology|October 21, 2016
Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapyDavid J Pinato, Robert J Shiner, Solomon D T White, et al.
Plos One|December 30, 2014
Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodesKevin Blighe, Laura Kenny, Naina Patel, et al.
Cancer|June 22, 2010
A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancerJonathan Shamash, Justin Stebbing, Chris Sweeney, et al.
Leukemia Research|May 9, 2009
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasiaEleftheria Hatzimichael, Leonidas Benetatos, Aggeliki Dasoula, et al.
Pageof 51

Showing results (381-390 of 504) with videos related to

Sort By:
Pageof 51
Heliyon|November 3, 2023
A prognostic model of drug tolerant persister-related genes in lung adenocarcinoma based on single cell and bulk RNA sequencing dataZhonghai Du, Tongtong Zhang, Yanke Lin, et al.
Journal of Clinical Pathology|May 19, 2011
Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talkJustin Stebbing, Arun Thiyagarajan, Veena Surendrakumar, et al.
Lancet (London, England)|August 28, 2015
The role of TP53 in miRNA loading onto AGO2 and in remodelling the miRNA-mRNA interaction networkJonathan Krell, Justin Stebbing, Adam Enver Frampton, et al.
Oncogene|April 8, 2022
PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38<sup>MAPK</sup> signallingRosemary Lane, Chiara Cilibrasi, Jianing Chen, et al.
European Journal of Haematology|September 10, 2009
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasiaEleftheria Hatzimichael, Aggeliki Dasoula, Reshma Shah, et al.
Plos One|May 14, 2013
The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept studyJustin Stebbing, Rachel Payne, Justine Reise, et al.
Oncoimmunology|October 21, 2016
Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapyDavid J Pinato, Robert J Shiner, Solomon D T White, et al.
Plos One|December 30, 2014
Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodesKevin Blighe, Laura Kenny, Naina Patel, et al.
Cancer|June 22, 2010
A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate-resistant prostate cancerJonathan Shamash, Justin Stebbing, Chris Sweeney, et al.
Leukemia Research|May 9, 2009
Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasiaEleftheria Hatzimichael, Leonidas Benetatos, Aggeliki Dasoula, et al.
Pageof 51